Markets
News
Analysis
Tools
Learn
Stock
Score
Scan to Download
One powerful score. Smarter investment decisions.
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
Log in
Start for free
Start for free
Markets
/
Stocks
/
nasdaq-lona
/
LeonaBio Ord Shs
LONA
4.580
USD
-0.210
-4.38%
Close 02/06, 16:00(ET)
Quotes delayed by 15 min
4.790
USD
+4.790
After-hours 02/09, 20:00 (ET)
18.06M
Market Cap
Loss
P/E TTM
LeonaBio Ord Shs
4.580
-0.210
-4.38%
Overview
Financials
Analysis
Company
Overview
Financials
Analysis
Company
More Details of Company
LeonaBio Ord Shs Info
Ticker Symbol
- -
Company name
- -
IPO date
- -
CEO
- -
Number of employees
- -
Security type
- -
Fiscal year-end
- -
Address
- -
City
- -
Stock exchange
- -
Country
- -
Postal code
- -
Phone
- -
Website
- -
Ticker Symbol
- -
IPO date
- -
CEO
- -
Company Executives of LeonaBio Ord Shs
Name
Name/Position
Position
Shareholding
Change
Dr. Mark James Litton, Ph.D.
Dr. Mark James Litton, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
42.80K
-2586.00%
Dr. Kevin Church, Ph.D.
Dr. Kevin Church, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
20.68K
-876.00%
Mr. Mark Worthington
Mr. Mark Worthington
Chief Compliance Officer, General Counsel, Company Secretary
Chief Compliance Officer, General Counsel, Company Secretary
13.98K
-876.00%
Mr. Robert Renninger
Mr. Robert Renninger
Senior Vice President - Finance, Accounting
Senior Vice President - Finance, Accounting
12.86K
-297.00%
Dr. Javier San Martin, M.D.
Dr. Javier San Martin, M.D.
Chief Medical Officer
Chief Medical Officer
10.19K
-1644.00%
Ms. Kelly A. Romano
Ms. Kelly A. Romano
Independent Chairwoman of the Board
Independent Chairwoman of the Board
8.07K
-2419.00%
Mr. Grant E. Pickering
Mr. Grant E. Pickering
Independent Director
Independent Director
2.58K
--
James A. Johnson ,
James A. Johnson ,
Independent Director
Independent Director
500.00
--
Ms. Barbara Kosacz, J.D.
Ms. Barbara Kosacz, J.D.
Independent Director
Independent Director
--
--
Mr. Joseph (Joe) Edelman
Mr. Joseph (Joe) Edelman
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Dr. Mark James Litton, Ph.D.
Dr. Mark James Litton, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
42.80K
-2586.00%
Dr. Kevin Church, Ph.D.
Dr. Kevin Church, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
20.68K
-876.00%
Mr. Mark Worthington
Mr. Mark Worthington
Chief Compliance Officer, General Counsel, Company Secretary
Chief Compliance Officer, General Counsel, Company Secretary
13.98K
-876.00%
Mr. Robert Renninger
Mr. Robert Renninger
Senior Vice President - Finance, Accounting
Senior Vice President - Finance, Accounting
12.86K
-297.00%
Dr. Javier San Martin, M.D.
Dr. Javier San Martin, M.D.
Chief Medical Officer
Chief Medical Officer
10.19K
-1644.00%
Ms. Kelly A. Romano
Ms. Kelly A. Romano
Independent Chairwoman of the Board
Independent Chairwoman of the Board
8.07K
-2419.00%
Revenue Breakdown
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Tue, Jan 13
Updated: Tue, Jan 13
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Perceptive Advisors LLC
47.14%
Acorn Capital Advisors, LLC
15.11%
Simplify Asset Management Inc
7.57%
Baselake Management, LLC
5.63%
Nemean Asset Management, LLC
4.09%
Other
20.45%
Shareholders
Shareholders
Proportion
Perceptive Advisors LLC
47.14%
Acorn Capital Advisors, LLC
15.11%
Simplify Asset Management Inc
7.57%
Baselake Management, LLC
5.63%
Nemean Asset Management, LLC
4.09%
Other
20.45%
Shareholder Types
Shareholders
Proportion
Private Equity
47.40%
Investment Advisor
28.70%
Corporation
9.73%
Individual Investor
4.14%
Hedge Fund
4.09%
Venture Capital
3.79%
Investment Advisor/Hedge Fund
2.15%
Family Office
0.98%
Research Firm
0.83%
Institutional Shareholding
Updated: Tue, Jan 13
Updated: Tue, Jan 13
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
107
3.43M
86.99%
+588.35K
2025Q4
113
3.34M
84.62%
+1.00M
2025Q3
123
1.85M
47.14%
-805.95K
2025Q2
137
1.88M
48.34%
-780.64K
2025Q1
169
1.88M
48.36%
-912.05K
2024Q4
181
1.93M
49.87%
-1.07M
2024Q3
198
1.93M
50.33%
-1.16M
2024Q2
215
2.54M
66.42%
-582.38K
2024Q1
233
2.49M
65.12%
-1.23M
2023Q4
240
2.51M
65.92%
-1.08M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Perceptive Advisors LLC
1.86M
47.14%
+1.32M
+244.13%
Dec 23, 2025
Acorn Capital Advisors, LLC
501.74K
12.72%
+501.74K
--
Dec 22, 2025
Simplify Asset Management Inc
298.56K
7.57%
--
--
Sep 30, 2025
Baselake Management, LLC
222.22K
5.63%
+222.22K
--
Nov 07, 2025
Nemean Asset Management, LLC
161.22K
4.09%
-38.25K
-19.17%
Oct 01, 2025
The Vanguard Group, Inc.
153.79K
3.9%
-2.00
-0.00%
Sep 30, 2025
Propel Bio Management, LLC
149.28K
3.79%
+149.28K
--
Dec 31, 2025
Tang Capital Management, LLC
60.00K
1.52%
-2.00
-0.00%
Sep 30, 2025
Renaissance Technologies LLC
51.92K
1.32%
+27.82K
+115.45%
Sep 30, 2025
Litton (Mark James)
45.38K
1.15%
+10.83K
+31.36%
Dec 31, 2025
View more
Related ETFs
Updated: Tue, Jan 13
Updated: Tue, Jan 13
Name
Proportion
Simplify Propel Opportunities ETF
1.54%
Dimensional US Core Equity 1 ETF
0%
iShares US Small-Cap Equity Factor ETF
0%
iShares Micro-Cap ETF
0%
DFA Dimensional US Sustainability Core 1 ETF
0%
iShares Neuroscience and Healthcare ETF
0%
Avantis US Small Cap Equity ETF
0%
Simplify Propel Opportunities ETF
Proportion
1.54%
Dimensional US Core Equity 1 ETF
Proportion
0%
iShares US Small-Cap Equity Factor ETF
Proportion
0%
iShares Micro-Cap ETF
Proportion
0%
DFA Dimensional US Sustainability Core 1 ETF
Proportion
0%
iShares Neuroscience and Healthcare ETF
Proportion
0%
Avantis US Small Cap Equity ETF
Proportion
0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Splits
Date
Ex-dividend Date
Type
Ratio
No Data
Date
Ex-dividend Date
Type
Ratio
No Data
KeyAI
Please log in to use KeyAI
Log in
Start for free